Balyasny Asset Management LLC Optimize Rx Corp Transaction History

Balyasny Asset Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$11.63 - $15.63 $45,124 - $60,644	3,880 Added 33.85%	15,342 $219,000
Q1 2023 May 15, 2023	BUY	$12.54 - $19.38 $143,733 - $222,133	11,462 New	11,462 $167,000
Q2 2022 Aug 15, 2022	SELL	$21.94 - $40.49 $168,938 - $311,773	-7,700 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$35.27 - $62.91 $271,579 - $484,407	7,700 New	7,700 $290,000
Q4 2021 Feb 14, 2022	SELL	$53.57 - $98.0 $271,171 - $496,076	-5,062 Closed	0 $0

Q3 2021 Nov 15, 2021	BUY	$50.93 - $85.55 $257,807 - $433,054	5,062 New	5,062 $433,000

101

12.9M

18.6K

1.1K

Ticker OPRX
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 18,023,100
Market Cap $180M
Description
OptimizeRx Corporation, a digital health technology company, provides various solutions to life sciences organizations, healthcare providers, and patients. The company's products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patien...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.